亚辉龙蹭热点，被证监会立案！

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Shenzhen Yahui Long Biotechnology Co., Ltd. (referred to as "Yahui Long") for suspected misleading statements related to a strategic cooperation framework agreement disclosed on January 7 [1][3]. Group 1: Investigation and Regulatory Actions - On February 6, Yahui Long received a notice from the CSRC regarding the investigation due to alleged violations of information disclosure laws [1][3]. - The CSRC emphasized that it will handle the case according to the law after a comprehensive investigation to maintain healthy market development [1]. - Yahui Long announced that its business operations are continuing normally and that it will cooperate with the CSRC during the investigation [1]. Group 2: Strategic Cooperation and Market Response - Yahui Long signed a strategic cooperation framework agreement with Shenzhen Brain Machine Starlink Technology Co., Ltd. (referred to as "Brain Machine Starlink") to develop brain-machine interface products [3][4]. - The announcement of this cooperation led to increased market attention, prompting the Shanghai Stock Exchange (SSE) to issue an inquiry letter requesting further details about the collaboration [3][5]. - Following regulatory scrutiny, Yahui Long clarified that Brain Machine Starlink's products are primarily in the early research and development stages and have not yet entered the registration phase [4][5]. Group 3: Market Performance - On January 6, the stock price of Yahui Long increased by 6.52%, with trading volume rising by 299% compared to the previous trading day [6].